DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 245 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,448,219 | -27.4% | 218,007 | -19.8% | 0.26% | -22.2% |
| Q1 2024 | $3,374,118 | -17.2% | 271,887 | -6.7% | 0.33% | -20.9% |
| Q4 2023 | $4,073,087 | -5.3% | 291,351 | 0.0% | 0.42% | -17.5% |
| Q3 2023 | $4,303,254 | +11.8% | 291,351 | -2.2% | 0.50% | +17.2% |
| Q2 2023 | $3,849,708 | +27.8% | 297,965 | -3.0% | 0.43% | +16.8% |
| Q1 2023 | $3,012,416 | -7.8% | 307,076 | 0.0% | 0.37% | -11.1% |
| Q4 2022 | $3,267,289 | +21.3% | 307,076 | +19.0% | 0.41% | -10.6% |
| Q3 2022 | $2,694,000 | +1008.6% | 258,009 | +1238.8% | 0.46% | +684.7% |
| Q2 2022 | $243,000 | +16.3% | 19,271 | 0.0% | 0.06% | +40.5% |
| Q1 2022 | $209,000 | -61.4% | 19,271 | -50.0% | 0.04% | -23.6% |
| Q4 2021 | $542,000 | +46.5% | 38,542 | +100.0% | 0.06% | -32.1% |
| Q3 2021 | $370,000 | – | 19,271 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,452,235 | $30,259,000 | 7.79% |
| Senvest Management, LLC | 4,874,129 | $17,449,000 | 1.50% |
| Bain Capital Public Equity Management II, LLC | 3,345,346 | $11,960,000 | 1.14% |
| Chicago Capital, LLC | 4,380,216 | $15,659,000 | 1.05% |
| Rhenman & Partners Asset Management AB | 1,234,335 | $4,413,000 | 0.55% |
| Sio Capital Management, LLC | 465,299 | $1,663,000 | 0.54% |
| RA Capital Management | 2,365,912 | $8,458,000 | 0.50% |
| Maven Securities LTD | 264,989 | $931,000 | 0.29% |
| Rock Springs Capital Management LP | 1,850,000 | $6,614,000 | 0.26% |
| GABLES CAPITAL MANAGEMENT INC. | 64,050 | $231,000 | 0.16% |